metastatic/advanced OC (mOC) - 2nd line (L2) | |
metastatic/advanced OC (mOC) - 2nd line (L2) | |
avelumab plus pegylated liposomal doxorubicin | JAVELIN ovarian 200 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -